JPRN-UMIN000012336已完成未知
Study for the effect of Stronger Neo-Minophagen C (SNMC) for nonalcoholic fatty liver disease (NAFLD)-multicenter clinical trial- - Study for the effect of SNMC for NAFLD
Division of Gstroenterological Mdicine, Kagoshima University Hospital0 个研究点目标入组 20 人开始时间: 2013年11月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. HBV or HCV infection. 2. Alcohol drinking more than 20g-ethanol per day. 3. Malignancy 4. Hepatic encephalopathy 5. Active infection 6. Severe complication 7. Pregnant, child-bearing potential or breast-feeding woman. 8. Ineligible for study judged by Medical Docor
研究者
相似试验
已完成
不适用
CRP study: The value of C-reactive protein (CRP) testing in acutely ill childreTopic: Primary Care Research Network for EnglandSubtopic: Not AssignedDisease: All DiseasesInfections and InfestationsISRCTN69736109niversity of Oxford (UK)700
尚未招募
3 期
Comparing collagen superabsorbent powder containing silver nanoparticles 15 ppm and 1% silver sulfadiazine ointmentBed Sore.IRCT20230621058552N2Esfahan University of Medical Sciences68
已完成
2 期
The effect of phototherapy and oral Simvastatin in treatment of vitiligoIRCT20150825023753N11Shiraz University of Medical Sciences50
已完成
3 期
A comparative study on the therapeutic effect of combined NBUVB and systemic Simvastatin with NBUVB alone in patients with vitiligoIRCT20191013045092N2Shiraz University of Medical Sciences50
进行中（未招募）
不适用
A phase IIa study to characterize the effects of CCL2 inhibition with the Spiegelmer® NOX-E36 in patients with type 2 diabetes mellitus and albuminuriadiabetes mellitus type II and albuminuriaMedDRA version: 14.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 14.1Level: PTClassification code 10001580Term: AlbuminuriaSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2011-005710-11-DEOXXON Pharma AG75